Thus, our data demonstrate that inhibition of JNK2 activity can protect against diabetes‐induced myocardial injury, and C66 protects the heart from diabetic cardiomyopathy by inhibiting JNK2 activity. This evidence concerns the gene MAPK9 and diabetic cardiomyopathy.